13F Insight
DOSSIER · 13F-HR · Q2 2026

SILVERARC CAPITAL MANAGEMENT, LLC

$962M in tracked AUM across 73 positions as of Q2 2026.

SC
CIK 0001816307 · last filed Jun 30, 2026
Total AUM
$962M
as of Q2 2026
Holdings
73
—
positions
Whale Score
61
61
tracked
Activity
—
no data
changes this Q
AI Analysis · Q2 2026

SILVERARC CAPITAL MANAGEMENT, LLC filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
K08588103
ASCENDIS PHARMA A/S
$55M206K5.7%02
CELC
CELCUITY INC
$52M501K5.4%03
COGT
COGENT BIOSCIENCES INC
$50M1.3M5.2%04
M96088105
UROGEN PHARMA LTD
$48M1.3M5.0%05
IMNM
IMMUNOME INC
$43M2.0M4.4%06
DNTH
DIANTHUS THERAPEUTICS INC
$38M390K4.0%07
RYTM
RHYTHM PHARMACEUTICALS INC
$35M311K3.6%08
ORKA
ORUKA THERAPEUTICS INC
$34M353K3.5%09
GLUE
MONTE ROSA THERAPEUTICS INC
$27M1.1M2.8%10
SNDX
SYNDAX PHARMACEUTICALS INC
$27M1.2M2.8%

Filing history

2026Q2Jun 30
$962M▼ 1.8%
73 positionsView →2026Q1Mar 31
$980M▲ 36.1%
73 positionsView →2025Q4Dec 31
$720M▲ 29.3%
68 positionsView →2025Q3Sep 30
$557M▲ 2.7%
65 positionsView →2025Q2Jun 30
$542M▲ 78.6%
65 positionsLocked2025Q1Mar 31
$304M▼ 33.6%
49 positionsLocked2024Q4Dec 31
$457M▲ 2.7%
61 positionsLocked2024Q3Sep 30
$445M▲ 5.1%
71 positionsLocked2024Q2Jun 30
$424M▲ 17.7%
70 positionsLocked2024Q1Mar 31
$360M▲ 7.2%
77 positionsLocked2023Q4Dec 31
$336M▲ 1.9%
67 positionsLocked2023Q3Sep 30
$330M▲ 2.0%
80 positionsLocked
Showing 12 of 23